pharmaceuticals News - The Latest News, Insight, Commentary & Analysis at Healthcare Asia Magazine

pharmaceuticals

What’s next for the global heparin market?

It is expected to witness a CAGR of 7.22% through 2028.
3 days ago

UAE pharmaceutical market to be valued at $7.9b by 2029

One driver is the new mandatory health insurance scheme for all private sector employees.
5 days ago

Alzheimer’s disease market across 8MM to hit 19.3b by 2033

DMTs are expected to account for 73.5% of the global market.

Glaucoma market to hit $2.5b in seven major markets by 2033

A report predicts the launch of six late-stage pipeline drugs during this period.

Global testosterone replacement therapy market to rise by $461m by 2029

Its growth is driven by a rising awareness of hypogonadism.

Heart failure market across 7MM to grow at 9.6% CAGR until 2032

One driver is the introduction of drugs targeting unmet needs.

Global pharmaceutical data and analytics market to double by 2028

China represents the largest market for the sector.

Global heparin market to grow by $3.34b by 2028

Key developments include fractionated and low-molecular-weight heparin for thrombosis management.

8MM respiratory syncytial virus prophylaxis market to hit $6.2b by 2030

Thanks to the introduction of new monoclonal antibodies and vaccines.

India’s biotech ambitions face talent and IP challenges

These concerns may lead to a struggle to attract leading drugmakers.

Pharma dose CMOs face slow growth amidst challenging market conditions

The global shortage of generic drugs has worsened over the past year.

Hong Kong pharmaceutical market to be valued at $3b by 2028

However, competition from neighbouring markets poses downside risks.

AI to accelerate drug discovery and development timelines

Over 3,000 drugs have been developed or repurposed using AI.

Malaysian pharmaceutical market to project modest growth amidst new reform

A new procurement system aims to address medicine shortages and supply chain disruptions.

Skills shortage hinders digital transformation in the pharma industry

Large and medium-sized companies view this as a greater concern compared to smaller enterprises.